James Leal Tandem Diabetes Care Inc (TNDM) insider trading activity

James Leal is Chief Manufacturing Officer of TANDEM DIABETES CARE INC. Currently has a direct ownership of 16,876 shares of TNDM, which is worth approximately $538,513. The most recent transaction as insider was on May 28, 2024, when has been sold 129 shares (Common Stock) at a price of $51.73 per share, resulting in proceeds of $6,673. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 16.9K

0% 3M change

80.57% 12M change

Total Value Held $538,513

James Leal Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 28 2024	SELL Payment of exercise price or tax liability	$6,673 $51.73 p/Share	129 Reduced 0.76%	16,876 Common Stock
May 28 2024	BUY Exercise of conversion of derivative security	-	310 Added 1.79%	17,005 Common Stock
May 15 2024	SELL Payment of exercise price or tax liability	$176,784 $47.37 p/Share	3,732 Reduced 18.27%	16,695 Common Stock
May 15 2024	BUY Exercise of conversion of derivative security	-	9,021 Added 32.11%	19,072 Common Stock
May 15 2024	BUY Grant, award, or other acquisition	$9,227 $15.64 p/Share	590 Added 4.92%	11,406 Common Stock
Feb 27 2024	SELL Payment of exercise price or tax liability	$3,417 $27.34 p/Share	125 Reduced 1.14%	10,816 Common Stock
Feb 27 2024	BUY Exercise of conversion of derivative security	-	309 Added 2.75%	10,941 Common Stock
Feb 15 2024	SELL Payment of exercise price or tax liability	$11,027 $24.29 p/Share	454 Reduced 4.1%	10,632 Common Stock
Feb 15 2024	BUY Exercise of conversion of derivative security	-	973 Added 8.12%	11,008 Common Stock
Nov 27 2023	SELL Payment of exercise price or tax liability	$2,511 $19.47 p/Share	129 Reduced 1.26%	10,113 Common Stock
Nov 27 2023	BUY Exercise of conversion of derivative security	-	310 Added 2.94%	10,242 Common Stock
Nov 15 2023	SELL Payment of exercise price or tax liability	$7,334 $18.2 p/Share	403 Reduced 3.9%	9,932 Common Stock
Nov 15 2023	BUY Exercise of conversion of derivative security	-	973 Added 8.66%	10,265 Common Stock
Nov 15 2023	BUY Grant, award, or other acquisition	$247 $15.47 p/Share	16 Added 0.17%	9,362 Common Stock
Aug 28 2023	SELL Payment of exercise price or tax liability	$3,490 $27.06 p/Share	129 Reduced 1.36%	9,346 Common Stock
Aug 28 2023	BUY Exercise of conversion of derivative security	-	310 Added 3.17%	9,475 Common Stock
Aug 15 2023	SELL Payment of exercise price or tax liability	$11,667 $28.88 p/Share	404 Reduced 4.22%	9,165 Common Stock
Aug 15 2023	BUY Exercise of conversion of derivative security	-	973 Added 9.29%	9,499 Common Stock
May 30 2023	SELL Payment of exercise price or tax liability	$3,400 $26.57 p/Share	128 Reduced 1.47%	8,596 Common Stock
May 30 2023	BUY Exercise of conversion of derivative security	-	309 Added 3.42%	8,724 Common Stock
May 15 2023	SELL Payment of exercise price or tax liability	$45,078 $32.13 p/Share	1,403 Reduced 14.29%	8,415 Common Stock
May 15 2023	BUY Exercise of conversion of derivative security	-	3,391 Added 25.81%	9,748 Common Stock
May 15 2023	BUY Grant, award, or other acquisition	$16,965 $27.32 p/Share	621 Added 8.81%	6,427 Common Stock
Feb 27 2023	SELL Payment of exercise price or tax liability	$5,201 $35.87 p/Share	145 Reduced 2.44%	5,806 Common Stock
Feb 27 2023	BUY Exercise of conversion of derivative security	-	310 Added 4.95%	5,951 Common Stock

James Leal

Chief Manufacturing Officer

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TNDM shares.

Notify only if

Value

Insider Trading

Get notified when an Tandem Diabetes Care Inc insider buys or sells TNDM shares.

Notify only if

Operation

Value

Type

News

Receive news related to TANDEM DIABETES CARE INC

Track Activities on TNDM

Account